BAH and BPI: Connecting common challenges

24.04.2023 16:15

With the aim of representing the interests of pharmaceutical companies operating in Germany even more effectively, the two industry associations, the Federal Association of Drug Manufacturers (BAH) and the Federal Association of the Pharmaceutical Industry (BPI), are once again holding discussions with the aim of merging.

The negotiating teams led by the two CEOs Jörg Wieczorek and Dr. Hans-Georg Feldmeier managed to reach agreement on key issues. A clear common goal and a constructive negotiating atmosphere are crucial for the good progress in the negotiations.

“We would like to combine the different strengths of the two associations in such a way that this creates noticeable added value for the companies organized in both associations,” emphasizes Wieczorek. “The trusting and constructive discussion on equal terms in all relevant topics of such a merger is the basis for the dynamic progress of the discussions,” adds Feldmeier. The aim is to successfully conclude the talks by the middle of the year and to complete the organizational implementation of the merger at the start of 2024.